To unleash immunotherapy on solid tumors, biotech turns to cell receptors

To unleash immunotherapy on solid tumors, biotech turns to cell receptors

Seeking to unleash immunotherapies on solid tumors, biotech homes in on cell receptors

By ANDREW JOSEPH @DrewQJoseph

JULY 9, 2018

Colorized scanning electron micrograph of a T lymphocyte.NIAID

T cell receptor, or TCR, therapies may be able to swarm and invade difficult-to-treat cancers in some patients where other treatments fail.

READ MORE